术前外周血SII、NLR、PLR、FAR、MLR及CA125在卵巢透明细胞癌诊断中的临床价值分析Analysis of the Preoperative Clinical Value of Peripheral Blood SII, NLR, PLR, FAR, MLR, and CA125 in the Diagnosis of Ovarian Clear Cell Carcinoma
张雯丽, 宋文静, 贺艺璇, 王丽杉, 陈爱平
临床医学进展Vol.14 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.142644, February 29 2024
晚期上皮性卵巢癌NACT-IDS的临床研究进展Progress in Clinical Research of NACT-IDS in Advanced Epithelial Ovarian Cancer
张 晴, 武晓红
临床医学进展Vol.13 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1351119, May 22 2023
SII、FAR及CA125水平与子宫内膜癌临床病理特征的关系Relation between the Levels of SII, FAR, CA125 and Clinicopathological Features of Endometrial Carcinoma
孙方圆, 赵晨园, 刘根利, 张 萍
临床医学进展Vol.11 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1112882, December 27 2021
术前系统免疫炎症指数和中性粒细胞/淋巴细胞比值与卵巢癌患者预后的关系The Prognostic Value of Systemic Immune-Inflammation Index and Neutrophil to Lymphocyte Ratio on the Prognosis of Ovarian Cancer
赵 飞, 丁朝霞, 陈爱平 科研立项经费支持
临床医学进展Vol.11 No.3, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.113161, March 19 2021
肿瘤标志物CA125，CA199，HE4及血HCG在卵巢恶性肿瘤中的表达与临床进展研究Expression and Clinical Progress of Tumor Markers CA125, CA199, HE4 and HCG in Ovarian Malignant Tumors
茹一鸣, 陈志芳
临床医学进展Vol.14 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.142615, February 29 2024
血清肿瘤标志物在卵巢恶性肿瘤诊断中的ROC曲线分析ROC Curve Analysis of Serum Tumor Markers in the Diagnosis of Ovarian Malignant Tumors
马沈倩, 任志帅, 刘 畅, 杨舒文, 郭玉琪 科研立项经费支持
临床医学进展Vol.12 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.12121663, December 26 2022